// App-Quantinova.ai

POS1260 (2022) : COVID-19 VACCINATION-RELATED ADVERSE EVENTS AMONG AUTOIMMUNE DISEASE PATIENTS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASES (COVAD) STUDY

Researchers

Presenter

  • P. Sen

Principal Investigators

  • A. Nune

  • J. B. Lilleker

  • V. Agarwal

  • S. Kardes

  • M. Kim

  • J. Day

  • M. Milchert

  • T. A. Gheita

  • B. Salim

  • T. Velikova

  • A. E. Gracia-Ramos

  • I. Parodis

  • A. Selva-Ocallaghan

  • E. Nikiphorou

  • T. Chatterjee

  • A. L. Tan

  • L. Cavagna

  • M. A. Saavedra

  • S. Katsuyuki Shinjo

  • N. Ziade

  • J. Knitza

  • M. Kuwana

  • O. Distler

  • H. Chinoy

  • R. Aggarwal

  • L. Gupta

Medical Centers

  • Maulana Azad Medical College, Pediatrics, New Delhi, India

  • Sanjay Gandhi Postgraduate Institute of Medical Sciences, Clinical Immunology and Rheumatology, Lucknow, Uttar Pradesh, India

  • Southport and Ormskirk Hospital NHS Trust, Southport, UK

  • School of Biological Sciences, The University of Manchester, Division of Musculoskeletal and Dermatological Sciences, Manchester, United Kingdom

  • Manchester Centre for Clinical Neurosciences, Neurology, Salford, United Kingdom

  • Mahatma Gandhi Mission Medical College, Navi Mumbai, India

  • Istanbul University Faculty of Medicine, Department of Medical Ecology and Hydroclimatology, Istanbul, Turkey

  • University of Illinois College of Medicine at Peoria, Department of Internal Medicine, Peoria, United States of America

  • Royal Melbourne Hospital, Department of Rheumatology, Parkville, Australia

  • Walter and Eliza Hall Institute of Medical Research, Parkville, Australia

  • The University of Melbourne, Department of Paediatrics, Parkville, Australia

  • Pomeranian Medical University in Szczecin, Department of Rheumatology, Internal Diseases, Geriatrics and Clinical Immunology, Szczecin, Poland

  • Kasr Al Ainy School of Medicine, Cairo University, Department of Rheumatology, Cairo, Egypt

  • Fauji Foundation Hospital, Department of Rheumatology, Rawalpindi, Pakistan

  • University Hospital Lozenetz, Department of Clinical Immunology, Sofia, Bulgaria

  • General Hospital, National Medical Center “La Raza”, Instituto Mexicano del Seguro Social, Department of Internal Medicine, Mexico City, Mexico

  • Karolinska Institutet and Karolinska University Hospital, Division of Rheumatology, Stockholm, Sweden

  • Örebro University Faculty of Medicine and Health, Department of Rheumatology, Örebro, Sweden

  • Vall d”Hebron General Hospital. Universitat Autonoma de Barcelona, Internal Medicine Dept, Barcelona, Spain

  • King’s College London, Centre for Rheumatic Disease, London, United Kingdom

  • King's College Hospital, Department of Rheumatology, London, London, United Kingdom

  • Leeds Teaching Hospitals NHS Trust, Leeds Biomedical Research Centre, Leeds, United Kingdom

  • University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

  • Fondazione I.R.C.C.S. Policlinico San Matteo, Department of Rheumatology, Pavia, Italy

  • Hospital de Especialidades Dr. Antonio Fraga Mouret, Centro Médico Nacional La Raza, IMSS, Department of Rheumatology, Mexico City, Mexico

  • Universidade de Sao Paulo Faculdade de Medicina FMUSP, Division of Rheumatology, Sao Paulo, Brazil

  • Saint-Joseph University, Rheumatology, Beirut, Lebanon

  • Hotel-Dieu de France Hospital, Rheumatology, Beirut, Lebanon

  • Friedrich-Alexander-Universität Erlangen-Nürnberg, Department of Rheumatology and Immunology, Erlangen, Germany

  • Nippon Medical School Graduate School of Medicine, Department of Allergy and Rheumatology, Tokyo, Japan

  • University Hospital Zurich, University of Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland

  • School of Biological Sciences The University of Manchester, Division of Musculoskeletal and Dermatological Sciences, Manchester, United Kingdom

  • National Institute for Health Research Manchester Musculoskeletal BioMedical Research Unit, Manchester, United Kingdom

  • Manchester Academic Health Science Centre, Department of Rheumatology, Salford, United Kingdom

  • University of Pittsburgh, Department of Medicine, Rheumatology and Clinical Immunology, Pittsburgh, United States of America

  • Royal Wolverhampton NHS Trust, Department of Rheumatology, Wolverhampton, United Kingdom

Locations

  • India

  • United Kingdom

  • Turkey

  • United States

  • Australia

  • Poland

  • Egypt

  • Pakistan

  • Bulgaria

  • Mexico

  • Sweden

  • Spain

  • Italy

  • Brazil

  • Lebanon

  • Germany

  • Japan

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

  • Multicenteric

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • CSL Limited

Result

  • N/A